Search results for VPS35 antibody

Anti-VPS35 antibody [HL1017], Abcam, AB308334

What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies . Conjugation ready Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications. Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.

VPS35 antibody [C3], C-term, Genetex, GTX108058

Anti-VPS35 antibody - C-terminal, Abcam, AB226180

Anti-VPS35 antibody [EPR11501(B)], Abcam, AB157220

What is this antibody validated in? Anti-VPS35 antibody [EPR11501(B)] (ab157220) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Flow Cytometry (Intra), Flow Cytometry (Flow Cyt), Immunohistochemistry (IHC-P), Immunocytochemistry/immunofluorescence (ICC/IF) in Human, Mouse samples. What is the molecular weight of VPS35? Anti-VPS35 [EPR11501(B)] (ab157220) specifically detects a band for VPS35 (UniProt: Q96QK1) at a molecular weight of 92kDa. Trusted by the scientific community Anti-VPS35 [EPR11501(B)] (ab157220) was first used in a scientific publication in 2013 and has been cited over 20 times in peer-reviewed journals. Trial sizes available! Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies. Specificity confirmed The specificity of Anti-VPS35 antibody [EPR11501(B)] (ab157220) has been confirmed by Western blot testing in VPS35 Knockout HAP1 cells. Other related products We have a range of other formats of antibody clone [EPR11501(B)] also available for your convenience: ab157220, HRP - ab215340 , Carrier free - ab240141 , APC - ab310829 , PE - ab310905 , Alexa Fluor® 594 - ab311695 , Alexa Fluor® 568 - ab312970 , Alexa Fluor® 555 - ab313179 , Alexa Fluor® 750 - ab321149 Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

VPS35 Antibody (YA3314)(PBS only), MedChemexpress, HY-P83569A

VPS35 Antibody (YA3314) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to VPS35.

PE Anti-VPS35 antibody [EPR11501(B)], Abcam, AB310905

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies . How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone.

APC Anti-VPS35 antibody [EPR11501(B)], Abcam, AB310829

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies . How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone.

Purified anti-VPS35 Antibody VPS35, A17084A, BioLegend, 856401

Purified anti-VPS35 Antibody VPS35, A17084A, BioLegend, 856402

HRP Anti-VPS35 antibody [EPR11501(B)], Abcam, AB215340

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .